F582-0111 Screening compound: N-[(4-chlorophenyl)methyl]-5-cyclopropanecarbonyl-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-3-carboxamide

F582-0111 Screening compound: N-[(4-chlorophenyl)methyl]-5-cyclopropanecarbonyl-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-3-carboxamide
F582-0111 Screening compound: N-[(4-chlorophenyl)methyl]-5-cyclopropanecarbonyl-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F582-0111
N-[(4-chlorophenyl)methyl]-5-cyclopropanecarbonyl-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F582-0111

Molecular Formula

C19H21ClN4O2 (C19 H21 ClN4 O2)

Compound Name

N-[(4-chlorophenyl)methyl]-5-cyclopropanecarbonyl-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-3-carboxamide

IUPAC name

N-[(4-chlorophenyl)methyl]-5-cyclopropanecarbonyl-1-methyl-1H4H5H6H7H-pyrazolo[43-c]pyridine-3-carboxamide

SMILES

Cn1nc(C(NCc(cc2)ccc2Cl)=O)c(C2)c1CCN2C(C1CC1)=O

InChI

InChI=1S/C19H21ClN4O2/c1-23-16-8-9-24(19(26)13-4-5-13)11-15(16)17(22-23)18(25)21-10-12-2-6-14(20)7-3-12/h2-3,6-7,13H,4-5,8-11H2,1H3,(H,21,25)

InChI Key

LFOXYPVKUUSCQT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27176944

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

372.85

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

1.852

Distribution Coefficient, logD

1.852

Water Solubility, LogSw

-2.83

Polar Surface Area

56.503

Acid Dissociation Constant (pKa)

11.46

Base Dissociation Constant (pKb)

11.40

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

42.10

F582-0111 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

Soluble Diversity Library (15920 compounds)

Targeted Diversity Library (40567 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with F582-0111 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F582-0111?
Check Price and Availability of F582-0111, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F582-0111 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F582-0111
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F582-0111
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F582-0111 available by request